CX3CR1 and Parkinson disease: CX3CR1 has been reported to exert neuroprotective effects in α-synucleinopathy models of PD by limiting neurotoxicity and attenuating inflammatory responses (Table 2) (Tristão et al., 2016; Vida et al., 2025).